Search by Drug Name or NDC

    NDC 63824-0250-01 Mucinex Sinus-Max 325; 10; 200; 5 mg/1; mg/1; ug/1; mg/1 Details

    Mucinex Sinus-Max 325; 10; 200; 5 mg/1; mg/1; ug/1; mg/1

    Mucinex Sinus-Max is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by RB Health (US) LLC. The primary component is ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 63824-0250
    Product ID 63824-250_64100c05-db8f-4750-96df-92bb3fe496d9
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Mucinex Sinus-Max
    Proprietary Name Suffix Pressure, Pain and Cough
    Non-Proprietary Name Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 325; 10; 200; 5
    Active Ingredient Units mg/1; mg/1; ug/1; mg/1
    Substance Name ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name RB Health (US) LLC
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 63824-0250-01 (63824025001)

    NDC Package Code 63824-250-01
    Billing NDC 63824025001
    Package 2 BLISTER PACK in 1 CARTON (63824-250-01) / 10 TABLET, FILM COATED in 1 BLISTER PACK
    Marketing Start Date 2018-11-15
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 8905706b-b9da-4520-8cf2-87d7c125edf3 Details

    Revised: 1/2022